Related Experiment Video
Updated: Aug 9, 2026
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
[Recent entities in soft tissue tumor pathology. Part 2]
Muriel Genevay1, Jean-Michel Coindre, Louis Guillou
1Institut Universitaire de Pathologie, rue du Bugnon 25, 1011 Lausanne, Suisse.
Annales De Pathologie
|July 5, 2003
Summary
This review details recently described malignant soft tissue tumors, including diagnostic criteria and differential diagnoses. It highlights the importance of immunohistochemistry and molecular pathology in identifying these rare tumors.
Area of Science:
- Pathology
- Oncology
- Histopathology
Context:
- Focuses on the pathology of soft tissue tumors.
- Reviews malignant entities of recent description.
- Discusses rare and newly identified soft tissue neoplasms.
Purpose:
- To describe recently characterized malignant soft tissue tumors.
- To outline diagnostic criteria, clinical presentation, and differential diagnoses.
- To emphasize the role of advanced diagnostic techniques.
Summary:
- Details soft tissue giant cell tumor, inflammatory myxohyaline tumor, inflammatory fibroblastic sarcoma, low grade fibromyxoid sarcoma, hyalinizing spindle cell tumor with giant rosettes, spindle cell liposarcoma, proximal type epithelioid sarcoma, and sclerosing epithelioid fibrosarcoma.
- Provides diagnostic criteria, clinical presentation, and differential diagnosis for each entity.
- Highlights the utility of immunohistochemistry and molecular pathology in identifying these tumors.
Impact:
- Aids pathologists in diagnosing newly described malignant soft tissue tumors.
- Enhances understanding of rare soft tissue neoplasms.
- Guides the application of molecular pathology and immunohistochemistry in soft tissue tumor diagnostics.
